Trial Profile
A Randomized, Open, Single-dose, 3-treatment, 3-period, 6-sequence Crossover Study in Healthy Male Subjects to Evaluate the Pharmacokinetics of GLA5PR GLARS-NF1 Tablet 150mg and LYRICA Capsule 75mg
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Pregabalin
- Indications Pain
- Focus Pharmacokinetics
- Sponsors GL PharmTech
- 06 Jan 2015 New trial record